110 related articles for article (PubMed ID: 7478259)
1. Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission.
Boireau A; Bordier F; Dubédat P; Doble A
Neurosci Lett; 1995 Jul; 195(1):9-12. PubMed ID: 7478259
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of riluzole in MPTP-treated mice.
Araki T; Kumagai T; Tanaka K; Matsubara M; Kato H; Itoyama Y; Imai Y
Brain Res; 2001 Nov; 918(1-2):176-81. PubMed ID: 11684056
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice.
Araki T; Kumagai T; Matsubara M; Ido T; Imai Y; Itoyama Y
Metab Brain Dis; 2000 Sep; 15(3):193-201. PubMed ID: 11206588
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents.
Ali SF; Newport GD; Slikker W
Ann N Y Acad Sci; 1996 Oct; 801():187-98. PubMed ID: 8959033
[TBL] [Abstract][Full Text] [Related]
5. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
[TBL] [Abstract][Full Text] [Related]
6. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice.
Ali SF; Newport GD; Holson RR; Slikker W; Bowyer JF
Brain Res; 1994 Sep; 658(1-2):33-8. PubMed ID: 7530580
[TBL] [Abstract][Full Text] [Related]
7. Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of glutamatergic neurotransmission.
Mary V; Wahl F; Stutzmann JM
Neurosci Lett; 1995 Dec; 201(1):92-6. PubMed ID: 8830323
[TBL] [Abstract][Full Text] [Related]
8. MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity.
Layer RT; Bland LR; Skolnick P
Brain Res; 1993 Oct; 625(1):38-44. PubMed ID: 8242398
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Abekawa T
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
[TBL] [Abstract][Full Text] [Related]
10. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity.
Imam SZ; Newport GD; Islam F; Slikker W; Ali SF
Brain Res; 1999 Feb; 818(2):575-8. PubMed ID: 10082851
[TBL] [Abstract][Full Text] [Related]
11. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.
Baldwin HA; Colado MI; Murray TK; De Souza RJ; Green AR
Br J Pharmacol; 1993 Mar; 108(3):590-6. PubMed ID: 8467354
[TBL] [Abstract][Full Text] [Related]
12. Exposure of mice to tobacco smoke attenuates the toxic effect of methamphetamine on dopamine systems.
Bondy SC; Ali SF; Kleinman MT
Toxicol Lett; 2000 Dec; 118(1-2):43-6. PubMed ID: 11137307
[TBL] [Abstract][Full Text] [Related]
13. Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.
Boireau A; Dubédat P; Bordier F; Peny C; Miquet JM; Durand G; Meunier M; Doble A
Neuroreport; 1994 Dec; 5(18):2657-60. PubMed ID: 7696626
[TBL] [Abstract][Full Text] [Related]
14. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.
Weihmuller FB; O'Dell SJ; Marshall JF
Synapse; 1992 Jun; 11(2):155-63. PubMed ID: 1626313
[TBL] [Abstract][Full Text] [Related]
15. Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
Boireau A; Miquet JM; Dubédat P; Meunier M; Doble A
Neuroreport; 1994 Oct; 5(16):2157-60. PubMed ID: 7865766
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
Andrés ME; Gysling K; Bustos G
Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
[TBL] [Abstract][Full Text] [Related]
17. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
Mathé JM; Nomikos GG; Schilström B; Svensson TH
J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002
[TBL] [Abstract][Full Text] [Related]
18. Effects of glutamate and MK-801 on the metabolism of dopamine in the striatum of normal and parkinsonian rats.
Duan CL; Sun XH; Ji M; Yang H
Sheng Li Xue Bao; 2005 Feb; 57(1):71-6. PubMed ID: 15719139
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine blocks repeated high-dose methamphetamine-induced behavioral sensitization to dizocilpine (MK-801), but not methamphetamine in rats.
Nakato Y; Abekawa T; Inoue T; Ito K; Koyama T
Neurosci Lett; 2011 Oct; 504(2):131-134. PubMed ID: 21945544
[TBL] [Abstract][Full Text] [Related]
20. Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia.
Boulenguez P; Peters SL; Mitchell SN; Chauveau J; Gray JA; Joseph MH
J Psychopharmacol; 1998; 12(3):258-67. PubMed ID: 10958252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
